American Journal of Cardiology
Volume 95, Issue 5 , Pages 553-557 , 1 March 2005

Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction

  • Gjin Ndrepepa, MD

      Affiliations

    • Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Munich, Germany
    • Corresponding Author InformationAddress for reprints: Gjin Ndrepepa, MD, Deutsches Herzzentrum, Lazarettstrasse 36, 80636 München, Germany
    • ,
  • Siegmund Braun, MD

      Affiliations

    • Institut für Laboratoriumsmedizin, Deutsches Herzzentrum München, Munich, Germany
    • ,
  • Julinda Mehilli, MD

      Affiliations

    • Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Munich, Germany
    • ,
  • Nicolas von Beckerath, MD

      Affiliations

    • Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Munich, Germany
    • ,
  • Wolfgang Vogt, MD

      Affiliations

    • Institut für Laboratoriumsmedizin, Deutsches Herzzentrum München, Munich, Germany
    • ,
  • Albert Schömig, MD

      Affiliations

    • Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Munich, Germany
    • 1 Medizinische Klinik Klinikum rechts der Isar, Technische Universität München, Munich, Germany
    • ,
  • Adnan Kastrati, MD

      Affiliations

    • Institut für Laboratoriumsmedizin, Deutsches Herzzentrum München, Munich, Germany

Received 10 August 2004 ,Accepted 14 October 2004.

References 

  1. Wiese S, Breyer T, Dragu A, Wakili R, Burkard T, Schmidt-Schweda S, et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length . Circulation . 2000;102:3074–3079
  2. Yoshimura M, Yasue H, Okumura K, Ogawa H, Jougasaki M, Mukoyama M, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure . Circulation . 1993;87:464–469
  3. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure . Circulation . 1994;90:195–203
  4. de Lemos JA , McGuire DK , Drazner MH . B-type natriuretic peptide in cardiovascular disease . Lancet . 2003;362:316–322
  5. Yandle TG , Richards AM , Gilbert A , Fisher S , Holmes S , Espiner EA . Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure . J Clin Endocrinol Metab . 1993;76:832–838
  6. Omland T , Aakvaag A , Vik-Mo H . Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment . Heart . 1996;76:232–237
  7. Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting . J Am Coll Cardiol . 2001;37:379–385
  8. Talwar S , Squire IB , Downie PF , Davies JE , Ng LL . Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina . Heart . 2000;84:421–424
  9. Kikuta K, Yasue H, Yoshimura M, Morita E, Sumida H, Kato H, et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina . Am Heart J . 1996;132:101–107
  10. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction . Circulation . 1993;88:82–91
  11. Arakawa N , Nakamura M , Aoki H , Hiramori K . Relationship between plasma level of brain natriuretic peptide and myocardial infarct size . Cardiology . 1994;85:334–340
  12. Omland T , Bonarjee VV , Lie RT , Caidahl K . Neurohumoral measurements as indicators of long-term prognosis after acute myocardial infarction . Am J Cardiol . 1995;76:230–235
  13. Jernberg T , Stridsberg M , Venge P , Lindahl B . N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation . J Am Coll Cardiol . 2002;40:437–445
  14. James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy . Circulation . 2003;108:275–281
  15. Jernberg T, Lindahl B, Siegbahn A, Andren B, Frostfeldt G, Lagerqvist B, et al. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease . J Am Coll Cardiol . 2003;42:1909–1916
  16. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes . N Engl J Med . 2001;345:1014–1021
  17. Rutherford JD , Braunwald E , Cohn PF . Chronic ischemic heart disease . In:  Braunwald E editors. Heart Disease: A Textbook of Cardiovascular Medicine . 3rd Ed. Philadelphia: WB Saunders; 1988;p. 1314–1378
  18. World Health Organization . Diabetes mellitus . WHO Tech Rep Ser . 1985;727:1–104
  19. Sokoll LJ, Collinson P, Gurr E, Haass M, Morton I, Nowatzke W, et al. Performance evaluation of Elecsys proBNP in a multicenter study . Clin Chem Lab Med . 2004;42:965–972
  20. Collinson PO , Barnes SC , Gaze DC , Galasko G , Lahiri A , Senior R . Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys trade mark 1010 and 2010 analysers . Eur J Heart Fail . 2004;6:365–368
  21. Marumoto K , Hamada M , Hiwada K . Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris . Clin Sci (Lond) . 1995;88:551–556
  22. Tateishi J , Masutani M , Ohyanagi M , Iwasaki T . Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty . Clin Cardiol . 2000;23:776–780
  23. Pan J, Fukuda K, Saito M, Matsuzaki J, Kodama H, Sano M, et al. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes . Circ Res . 1999;84:1127–1136
  24. Nakao K, Mukoyama M, Hosoda K, Suga S, Ogawa Y, Saito Y, et al. Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide . Can J Physiol Pharmacol . 1991;69:1500–1506
  25. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, et al  Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction . Circulation . 1995;92:1558–1564
  26. Goetze JP, Christoffersen C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, et al. Increased cardiac BNP expression associated with myocardial ischemia . FASEB J . 2003;17:1105–1107
  27. Hopkins WE , Chen Z , Fukagawa NK , Hall C , Knot HJ , LeWinter MM . Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease (Enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion) . Circulation . 2004;109:2872–2877
  28. Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes . Circulation . 2002;106:2913–2918

PII: S0002-9149(04)01769-2

doi: 10.1016/j.amjcard.2004.10.034

American Journal of Cardiology
Volume 95, Issue 5 , Pages 553-557 , 1 March 2005

Article Tools

* Image Usage & Resolution